NCT02241395撤回1 期
Autologous Bone Marrow Mononuclear Cell Therapy in Cerebral Palsy
适应症
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- change in clinical symptoms over a period of 2 years
研究概览
简要总结
The purpose of this study was to study the effect of autologous bone marrow mononuclear cells on common symptoms of cerebral palsy patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 6 Months 至 35 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •diagnosed cases of any type of Cerebral Palsy
- •age above 6 months.
排除标准
- •presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/ Hepatitis C Virus
- •malignancies
- •bleeding tendencies
- •pneumonia
- •renal failure
- •severe liver dysfunction
- •severe anemia [Hemoglobin < 8]
- •any bone marrow disorder
- •space occupying lesion in brain
- •other acute medical conditions such as respiratory infection and pyrexia.
结局指标
主要结局
change in clinical symptoms over a period of 2 years
时间窗: 2 years
Clinical symptoms such as oromotor skills, sitting and standing balance, speech, ambulation, muscle tone, cognition, hand and leg movement, walking, etc
次要结局
- Change in GMFM score(1 year)
- Change in Gross Motor Function Measure(1 year)
研究者
研究点 (2)
Loading locations...
相似试验
撤回
1 期
Stem Cell Therapy in Muscular DystrophyMuscular DystrophyNCT02241928Neurogen Brain and Spine Institute
撤回
1 期
Stem Cell Therapy in Incurable Neurological DisordersDisorder, Nervous System NeurologicalNCT02245776Neurogen Brain and Spine Institute
Unknown
不适用
Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI)Left Ventricular Function Systolic DysfunctionLeft Ventricular Function Diastolic DysfunctionMyocardial Reperfusion InjuryDeathNCT01307371Xijing Hospital110
已完成
1 期
Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina BifidaStem Cell InfusionNCT05472428Vinmec Research Institute of Stem Cell and Gene Technology11
已完成
1 期
Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT01677013Peking University Aerospace Center Hospital1,026